Abingdon Health (LON:ABDX) trading up 2.3%

Vaseline

July 21, 2024

Abingdon Health Plc (LON:ABDX – Get Free Report) jumped 2.3% in midday trading on Friday. The stock traded as high as GBX 11.50 ($0.15), having last traded at GBX 11 ($0.14). 26,820 shares changed hands during the trade, a decline of 90% on its average session volume of 260,570 shares. The stock previously closed at GBX 10.75 ($0.14).

Abingdon Health Stock Return

The stock’s 50-day moving average is GBX 10.79 and its 200-day moving average is GBX 9.78. The stock has a market cap of £13.94 million, a price to earnings ratio of -1,100.00 and a beta of 0.09. The company has a debt to equity ratio of 55.57, a current ratio of 1.79 and a quick ratio of 1.96.

Abingdon Health Company Profile

(Get free report)

Abingdon Health Plc is engaged in the development, manufacture and distribution of diagnostic devices in the UK, USA, Canada, Europe and internationally. The company supplies Abingdon Simply Test, a range of self-tests in the areas of fertility, health and wellbeing, infectious diseases and drug testing; PCRD and PCRD FLEX, nucleic acid lateral flow tests, used for rapid readouts following isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health testing; and nucleic acid lateral flow immunoassays.

Shop Growlies